Free shipping on all orders over $ 500

Thiabendazole

Cat. No. M3315

All AbMole products are for research use only, cannot be used for human consumption.

Thiabendazole Structure
Synonym:

2-(4-Thiazolyl)benzimidazole

Size Price Availability Quantity
500mg USD 25 In stock
1g USD 35 In stock
5g USD 50 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Thiabendazole inhibites the mitochondrial helminth-specific enzyme, fumarate reductase, with possible interaction with endogenous quinone.A benzimidazole derivative with anthelminthic property. Thiabendazole inhibits the helminth-specific mitochondrial enzyme fumarate reductase, thereby inhibiting the citric acid cycle, mitochondrial respiration and subsequent production of ATP, ultimately leading to helminth’s death.

Chemical Information
Molecular Weight 201.25
Formula C10H7N3S
CAS Number 148-79-8
Form Solid
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] V K Shormanov, et al. Determination of thiabendazole in the conditions of chemical and toxicological analysis of biomaterial

[2] Xiong-Xin Peng, et al. Highly sensitive and rapid detection of thiabendazole residues in oranges based on a luminescent Tb 3+-functionalized MOF

[3] Cesar Henriquez-Camacho, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection

[4] Rafael Igual-Adell, et al. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis

[5] H J Robinson, et al. Thiabendazole: toxicological, pharmacological and antifungal properties

Related Mitochondrial Related Products
FCCP

FCCP is a mitochondrial uncoupling agent and an oxidative phosphorylation (OXPHOS) inhibitor. FCCP is often used as an apoptosis inducer.

Lixumistat

Lixumistat (IM156) is a novel biguanide mitochondrial protein complex 1 inhibitor of oxidative phosphorylation (OXPHOS) with anti-tumor activity. Lixumistat regulates OXPHOS to attenuate mitochondrial metabolic reprogramming and inhibit lung fibrosis. Lixumistat (IM156) is a metformin derivative, which increases AMPK phosphorylation.

KL1333

KL1333 is an orally available, small organic molecule that reacts with NAD(P)H:quinone oxidoreductase 1 (NQO1) as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation.

Mito-TEMPO

Mito-TEMPO (MT) is a mitochondrial-targeted superoxide dismutase mimetic that protects the early stages of acetaminophen (APAP) hepatotoxicity by inhibiting the formation of peroxynitrite. Mito-TEMPO treatment inhibits APAP-induced EXPRESSION OF RIP3 kinase.

VLX600

VLX600 is a novel inhibitor of iron-chelated oxidative phosphorylation (OXPHOS). VLX600 causes mitochondrial dysfunction and can show enhanced cytotoxicity in nutrient deficiency conditions. VLX600 showed selective cytotoxic activity against malignant cells and induced autophagy and had anticancer activity.*The compound is unstable in solutions, freshly prepared is recommended

  Catalog
Abmole Inhibitor Catalog




Keywords: Thiabendazole, 2-(4-Thiazolyl)benzimidazole supplier, Mitochondrial Related, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.